<VariationArchive RecordType="classified" VariationID="5874" VariationName="NM_004836.7(EIF2AK3):c.1035dup (p.Lys346Ter)" VariationType="Duplication" Accession="VCV000005874" Version="2" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2023-03-26" DateCreated="2017-10-08" MostRecentSubmission="2023-03-18">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="20913" VariationID="5874">
      <GeneList>
        <Gene Symbol="EIF2AK3" FullName="eukaryotic translation initiation factor 2 alpha kinase 3" GeneID="9451" HGNC_ID="HGNC:3255" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2p11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="88556741" stop="88628145" display_start="88556741" display_stop="88628145" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="88856258" stop="88927093" display_start="88856258" display_stop="88927093" Strand="-" />
          </Location>
          <OMIM>604032</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_004836.7(EIF2AK3):c.1035dup (p.Lys346Ter)</Name>
      <CanonicalSPDI>NC_000002.12:88590572:AA:AAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2p11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="88590572" stop="88590573" display_start="88590572" display_stop="88590573" variantLength="1" positionVCF="88590572" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="88890090" stop="88890091" display_start="88890090" display_stop="88890091" variantLength="1" positionVCF="88890090" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
      </Location>
      <ProteinChange>K346*</ProteinChange>
      <ProteinChange>K195*</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1024" sequenceAccession="LRG_1024">
            <Expression>LRG_1024:g.42004dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1024t1" sequenceAccession="LRG_1024t1">
            <Expression>LRG_1024t1:c.1035dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1024p1" sequenceAccession="LRG_1024p1" change="p.Lys346Ter">
            <Expression>LRG_1024p1:p.Lys346Ter</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.88890092dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.88890092dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.88590574dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.88590574dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016424.1" sequenceAccession="NG_016424" sequenceVersion="1" change="g.42004dup">
            <Expression>NG_016424.1:g.42004dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001313915.2" sequenceAccession="NM_001313915" sequenceVersion="2" change="c.582dup">
            <Expression>NM_001313915.2:c.582dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001300844.1" sequenceAccession="NP_001300844" sequenceVersion="1" change="p.Lys195Ter">
            <Expression>NP_001300844.1:p.Lys195Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004836.7" sequenceAccession="NM_004836" sequenceVersion="7" change="c.1035dup" MANESelect="true">
            <Expression>NM_004836.7:c.1035dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004827.4" sequenceAccession="NP_004827" sequenceVersion="4" change="p.Lys346Ter">
            <Expression>NP_004827.4:p.Lys346Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA351490" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="604032.0001" DB="OMIM" />
        <XRef Type="rs" ID="869025178" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 10932183 Fig. 2a to determine the location of this allele on the current reference sequence.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004836.7(EIF2AK3):c.1035dup (p.Lys346Ter) AND Wolcott-Rallison dysplasia" Accession="RCV000006232" Version="4">
        <ClassifiedConditionList TraitSetID="1631">
          <ClassifiedCondition DB="MedGen" ID="C0432217">Wolcott-Rallison dysplasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-02-23" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-02-23" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2017-10-08" MostRecentSubmission="2023-03-18">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10932183</ID>
        </Citation>
        <Citation Type="general">
          <CitationText>Nicolino, P. M., Dupin, H., Macebeo, V., Treppoz, S., Chatelain, P. G. Wolcott-Rallison syndrome (diabetes mellitus and spondyloepiphyseal dysplasia) : a plausible existence of a gene(s) important for the mutation of neonatal pancreatic beta cell function. (Abstract) Hormone Res. 50 (suppl. 3): 77-only, 1998.</CitationText>
        </Citation>
        <ConditionList>
          <TraitSet ID="1631" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5037" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Wolcott-Rallison dysplasia</ElementValue>
                <XRef ID="Epiphyseal+Dysplasia+Multiple+with+Early-Onset+Diabetes+Mellitus/2619" DB="Genetic Alliance" />
                <XRef ID="254066006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Wolcott-Rallison syndrome</ElementValue>
                <XRef ID="MONDO:0009192" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5589" />
                <XRef ID="5589" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Wolcott-Rallison syndrome is a rare autosomal recessive disorder characterized by permanent neonatal or early infancy insulin-dependent diabetes. Epiphyseal dysplasia, osteoporosis, and growth retardation develop at a later age. Other frequent multisystem manifestations include hepatic and renal dysfunction, mental retardation, and cardiovascular abnormalities (summary by Delepine et al., 2000).</Attribute>
                <XRef Type="MIM" ID="226980" DB="OMIM" />
              </AttributeSet>
              <XRef ID="1667" DB="Orphanet" />
              <XRef ID="C0432217" DB="MedGen" />
              <XRef ID="MONDO:0009192" DB="MONDO" />
              <XRef Type="MIM" ID="226980" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="26414" SubmissionDate="2017-10-05" DateLastUpdated="2017-10-08" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="604032.0001_WOLCOTT-RALLISON SYNDROME" title="EIF2AK3, 1-BP INS, 1103T_WOLCOTT-RALLISON SYNDROME" />
        <ClinVarAccession Accession="SCV000026414" DateUpdated="2017-10-08" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2000-08-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 3 affected Tunisian sibs with Wolcott-Rallison syndrome, Delepine et al. (2000) identified homozygosity for an insertion (T) at nucleotide position 1103 (1103insT) in the EIF2AK3 gene, creating a frameshift at amino acid position 345 and a premature termination at lys345. The mutation was not found in their unaffected parents, who were related as first cousins, or in their unaffected sib. The family had previously been reported by Nicolino et al. (1998).</Attribute>
              <Citation>
                <ID Source="PubMed">10932183</ID>
              </Citation>
              <Citation>
                <CitationText>Nicolino, P. M., Dupin, H., Macebeo, V., Treppoz, S., Chatelain, P. G. Wolcott-Rallison syndrome (diabetes mellitus and spondyloepiphyseal dysplasia) : a plausible existence of a gene(s) important for the mutation of neonatal pancreatic beta cell function. (Abstract) Hormone Res. 50 (suppl. 3): 77-only, 1998.</CitationText>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EIF2AK3" />
          </GeneList>
          <Name>EIF2AK3, 1-BP INS, 1103T</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 1103T</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="604032.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">WOLCOTT-RALLISON SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7171099" SubmissionDate="2023-03-09" DateLastUpdated="2023-03-18" DateCreated="2023-03-18">
        <ClinVarSubmissionID localKey="2-88890090-T-TA" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003841426" DateUpdated="2023-03-18" DateCreated="2023-03-18" Type="SCV" Version="1" SubmitterName="3billion" OrgID="507830" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10932183</ID>
          </Citation>
          <Comment>The variant is not observed in the gnomAD v2.1.1 dataset. This variant was predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported to be associated with EIF2AK3 related disorder (ClinVar ID: VCV000005874 / PMID: 10932183). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000857" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EIF2AK3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004836.7:c.1035dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="226980" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12919228</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7171099" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000857" MappingRef="HP">
        <MedGen CUI="C3278636" Name="Neonatal insulin-dependent diabetes mellitus" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7171099" TraitType="Disease" MappingType="XRef" MappingValue="226980" MappingRef="OMIM">
        <MedGen CUI="C0432217" Name="Wolcott-Rallison dysplasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="26414" TraitType="Disease" MappingType="Name" MappingValue="WOLCOTT-RALLISON SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0432217" Name="Wolcott-Rallison dysplasia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

